CURIS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CURIS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $22.00K.
- CURIS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $48.00K, a 166.67% increase year-over-year.
- CURIS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $79.00K.
- CURIS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CURIS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $727.00K.
- CURIS, INC. stock issued during period, value, stock options exercised for fiscal 2017 was -$42.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 | |
| 2021-09-30 | $22.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $48.00K 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $79.00K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $727.00K 10-K · filed 2022-02-24 | |
| 2020-06-30 | $18.00K 10-Q · filed 2021-11-09 | |
| 2017-12-31 | -$42.00K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |